Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
TORONTO and PERTH, Western Australia, March 19, 2026 (GLOBE NEWSWIRE) -- Further to its ASX announcement on 13 March 2026, Cygnus Metals Limited (“Cygnus” or the “Company”) has today issued a total...
-
Immutep has completed the single ascending dose (SAD) portion of its IMP761 study IMP761 was well tolerated across all dose levels IMP761 data and Phase I results will be presented at the EULAR...
-
Mobilicom is one of only four companies to be exempted from import restrictions under the Covered List and the only company to have multiple products exempted Mobilicom is expanding its production...
-
NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host its inaugural R&D Day...
-
DENVER, March 16, 2026 (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the “Company”) has been selected to provide feedstock for the Department of Energy...
-
Palo Alto, California, March 16, 2026 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW) (“Mobilicom” or the “Company”), a provider of cybersecurity and robust solutions for drones and...
-
TORONTO, March 16, 2026 (GLOBE NEWSWIRE) -- DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or “the Company”) announced today that the Toronto Stock Exchange (“TSX”) accepted its...
-
Anchorage Alaska, March 16, 2026 (GLOBE NEWSWIRE) -- Nova Minerals Limited (“Nova” or the “Company”) (NASDAQ: NVA) (ASX: NVA) (FRA: QM3) ) is pleased to announce that the mobilization of heavy...
-
Perth, Western Australia, March 16, 2026 (GLOBE NEWSWIRE) -- PERSEUS ANNOUNCES SALE OF GROUP INTEREST IN MEYAS SAND PROJECT IN SUDAN HIGHLIGHTS Perseus has signed a Share Purchase Agreement (SPA)...
-
MELBOURNE, Australia and INDIANAPOLIS, March 16, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the resubmission of a New Drug Application...